As a result of the excessive capital requirement and myriad of other complexities associated with clinical trials, pharmaceutical industry is increasingly relying on AI software and service providers to achieve desired outcomes

Roots Analysis is pleased to announce the publication of its recent study, titled, “AI in Clinical Trials Market (2nd Edition): AI Software and Service Providers, 2023-2035”

The report features an extensive study of the current market landscape, market size and future opportunities associated with the AI in clinical trials market, during the given forecast period. Further, the report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry. Key takeaways of the AI in clinical trials market report includes: